Profilo
Christopher Baldwin is currently Chief Commercial Officer at BCAL Diagnostics Ltd. Formerly, Dr. Baldwin was Chief Commercial Officer & Deputy CEO at Exopharm Ltd. from 2021 to 2022 and Executive Director at New York Blood Center, Inc. Education includes a doctorate from Trinity College.
Posizioni attive di Christopher Baldwin
| Società | Posizione | Inizio |
|---|---|---|
| BCAL DIAGNOSTICS LIMITED | Corporate Officer/Principal | - |
Precedenti posizioni note di Christopher Baldwin
| Società | Posizione | Fine |
|---|---|---|
| EXOPHARM | Corporate Officer/Principal | 01/02/2022 |
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Direttore/Membro del Consiglio | - |
Formazione di Christopher Baldwin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Health Services |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BCAL Diagnostics Ltd.
BCAL Diagnostics Ltd. Medical/Nursing ServicesHealth Services Engages in medical research and testing services | Health Services |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
















